chr1-176556816-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020318.3(PAPPA2):āc.494G>Cā(p.Gly165Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020318.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PAPPA2 | NM_020318.3 | c.494G>C | p.Gly165Ala | missense_variant | 2/23 | ENST00000367662.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PAPPA2 | ENST00000367662.5 | c.494G>C | p.Gly165Ala | missense_variant | 2/23 | 1 | NM_020318.3 | P1 | |
PAPPA2 | ENST00000367661.7 | c.494G>C | p.Gly165Ala | missense_variant | 2/5 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152078Hom.: 0 Cov.: 32 FAILED QC
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248878Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135032
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727246
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 152078Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74274
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 26, 2024 | The c.494G>C (p.G165A) alteration is located in exon 2 (coding exon 1) of the PAPPA2 gene. This alteration results from a G to C substitution at nucleotide position 494, causing the glycine (G) at amino acid position 165 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at